Abstract
Helicobacter pylori (HP) eradication therapy is a useful treatment for idiopathic thrombocytopenic purpura (ITP). Some investigators have also reported the effects of proton pump inhibitor (PPI) monotherapy on ITP. We performed a randomized study of HP eradication therapy and PPI monotherapy on ITP. Four of nine patients achieved complete remission (CR), two of nine achieved partial remission (PR) in HP eradication therapy, three of eight achieved CR, and two of eight achieved PR in PPI monotherapy. No significant differences were observed in the CR + PR of these patients between HP eradication therapy and PPI monotherapy. As for cost comparisons, HP eradication therapy is cheaper than PPI monotherapy, but it is less effective.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
2-Pyridinylmethylsulfinylbenzimidazoles
-
Aged
-
Amoxicillin / administration & dosage*
-
Amoxicillin / economics
-
Anti-Bacterial Agents / administration & dosage*
-
Anti-Bacterial Agents / economics
-
Anti-Ulcer Agents / administration & dosage*
-
Anti-Ulcer Agents / economics
-
Clarithromycin / administration & dosage*
-
Clarithromycin / economics
-
Drug Therapy, Combination
-
Helicobacter Infections / complications
-
Helicobacter Infections / drug therapy*
-
Helicobacter Infections / economics
-
Helicobacter Infections / enzymology
-
Helicobacter pylori*
-
Humans
-
Lansoprazole
-
Male
-
Middle Aged
-
Omeprazole / administration & dosage
-
Omeprazole / analogs & derivatives*
-
Omeprazole / economics
-
Proton Pump Inhibitors
-
Purpura, Thrombocytopenic, Idiopathic* / complications
-
Purpura, Thrombocytopenic, Idiopathic* / economics
-
Purpura, Thrombocytopenic, Idiopathic* / enzymology
-
Remission Induction
-
Treatment Outcome
Substances
-
2-Pyridinylmethylsulfinylbenzimidazoles
-
Anti-Bacterial Agents
-
Anti-Ulcer Agents
-
Proton Pump Inhibitors
-
Lansoprazole
-
Amoxicillin
-
Clarithromycin
-
Omeprazole